BGM
BGM Group Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$8.97
+3.70%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$9.35
From 52W high−16.56%
Volume5964.00
Market cap$119.79M
P/E (TTM)—
P/S (TTM)3.2x
Div yield—
Key dataOct 19, 2026
Open
$9.35
From 52W high
−16.56%
Volume
5964.00
Market cap
$119.79M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−10.0x
P/E (TTM)
—
RSI (14)
68.3
MomentumView details →
1D Return
+3.70%
YTD Return
+128.18%
SummaryUpdated Mar 1, 2026
BGM Group Ltd. (NASDAQ:BGM) is a Chinese pharmaceutical and agricultural company that manufactures and distributes active pharmaceutical ingredients, traditional Chinese medicine derivatives, and organic fertilizers. Originally incorporated in 2019 as Qilian International Holding Group Limited, the company rebranded to BGM Group Ltd. in October 2024. Headquartered in Chengdu, China, BGM operates as a specialty manufacturer serving both the pharmaceutical and agricultural sectors, with its products ranging from licorice-based medicines to heparin preparations and organic fertilizers.
Similar companies
Latest newsMore news →
No recent news for BGM.